Trials / Completed
CompletedNCT00191204
Open Label Phase III Duloxetine Study for Stress Urinary Incontinence
Long Term Monitoring of Safety in Subjects Treated With Duloxetine for Stress Urinary Incontinence
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 363 (planned)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to monitor the long term safety of duloxetine in the treatment of stress urinary incontinence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine |
Timeline
- Start date
- 2001-09-01
- Completion
- 2006-05-01
- First posted
- 2005-09-19
- Last updated
- 2007-01-26
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00191204. Inclusion in this directory is not an endorsement.